Outcome of patients younger than 50 years old diagnosed with myelodysplastic syndromes (MDS): Single institution experience.

被引：0
|
作者：
Al-Kali, Aref [1 ]
He, Rong [1 ]
Patnaik, Mrinal [1 ]
Hanna, Karen [1 ]
Viswanatha, David [1 ]
Greipp, Patricia T. [1 ]
Zblewski, Darci [1 ]
Elliott, Michelle A. [1 ]
Litzow, Mark Robert [1 ]
Nguyen, Phuong L. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18560
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience
    Al-Kali, Aref
    He, Rong
    Patnaik, Mrinal M.
    Viswanatha, David S.
    Greipp, Patricia T.
    Zblewski, Darci
    Elliott, Michelle
    Gangat, Naseema
    Tefferi, Ayalew
    Litzow, Mark R.
    Nguyen, Phuong L.
    BLOOD, 2016, 128 (22)
  • [2] Myelodysplastic syndromes in patients under 50 years old: a single institution experience
    Breccia, M
    Mengarelli, A
    Mancini, M
    Biondo, F
    Gentilini, F
    Latagliata, R
    Mandelli, F
    Alimena, G
    LEUKEMIA RESEARCH, 2005, 29 (07) : 749 - 754
  • [3] Myelodysplastic syndromes in patients younger than age 50
    Kuendgen, Andrea
    Strupp, Corinna
    Aivado, Manuel
    Hildebrandt, Barbara
    Haas, Rainer
    Gattermann, Norbert
    Germing, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5358 - 5365
  • [4] High-dose of epoietin alfa in patients with low-risk myelodysplastic syndromes (MDS): A single institution experience.
    Mele, G
    Musto, C
    Matera, R
    Vigliotti, ML
    Tartarone, A
    Romano, G
    Coccaro, M
    Di Renzo, N
    BLOOD, 2004, 104 (11) : 260B - 260B
  • [5] Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience
    Duek, Adrian
    Trakhtenbrot, Luba
    Avigdor, Abraham
    Nagler, Arnon
    Leiba, Merav
    ACTA HAEMATOLOGICA, 2021, 144 (01) : 58 - 65
  • [6] Presence of interstitial lung diseases (ILD) in patients diagnosed with myelodysplastic syndromes (MDS): Mayo Clinic experience.
    Nanah, Rama
    Zblewski, Darci
    Patnaik, Mrinal M.
    Begna, Kebede
    Ketterling, Rhett P.
    Iyer, Vivek
    Hogan, William J.
    Litzow, Mark Robert
    Ai-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Outcome of patients with myelodysplastic syndromes - experience from a single institution in South Australia
    Hui, C-H.
    Horvath, N.
    Lewis, I.
    To, L-B
    Szabo, F.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (11) : 824 - 828
  • [8] Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience
    Breccia, Massimo
    Finsinger, Paola
    Loglisci, Giuseppina
    Santopietro, Michelina
    Salaroli, Driano
    Serrao, Alessandra
    Latagliata, Roberto
    Volpicelli, Paola
    Petrucci, Luigi
    Nanni, Mauro
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2439 - 2443
  • [9] Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes
    Li, Xiao
    Xiao, Zhi-jian
    Chang, Chun-kang
    Xu, Feng
    Wu, Ling-yun
    He, Qi
    Xu, Ze-feng
    Song, Lu-xi
    Zhang, Zheng
    Zhou, Li-yu
    Su, Ji-ying
    Zhang, Xi
    Guo, Juan
    PLOS ONE, 2013, 8 (02):
  • [10] RESULTS OF CURRENT PRACTICES IN THE MANAGEMENT OF MYELODYSPLASTIC SYNDROMES (MDS): A SINGLE INSTITUTION EXPERIENCE
    Kashiwagi, E.
    Yamamoto, Y.
    Iizuka, M. Petersen
    Ogata, K.
    LEUKEMIA RESEARCH, 2015, 39 : S116 - S117
12345